NDUFA2 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	35 studies	32% ± 11%	Explore
B cell	32 studies	29% ± 11%	Explore
macrophage	29 studies	37% ± 14%	Explore
CD8-positive, alpha-beta T cell	29 studies	33% ± 14%	Explore
CD4-positive, alpha-beta T cell	28 studies	31% ± 13%	Explore
T cell	27 studies	31% ± 11%	Explore
conventional dendritic cell	27 studies	40% ± 15%	Explore
endothelial cell	27 studies	33% ± 14%	Explore
fibroblast	27 studies	30% ± 13%	Explore
classical monocyte	25 studies	37% ± 14%	Explore
non-classical monocyte	22 studies	40% ± 14%	Explore
smooth muscle cell	21 studies	29% ± 9%	Explore
pericyte	21 studies	33% ± 11%	Explore
regulatory T cell	21 studies	32% ± 8%	Explore
epithelial cell	20 studies	43% ± 22%	Explore
memory B cell	19 studies	24% ± 7%	Explore
plasmacytoid dendritic cell	19 studies	37% ± 13%	Explore
monocyte	17 studies	41% ± 13%	Explore
basal cell	17 studies	33% ± 18%	Explore
gamma-delta T cell	17 studies	29% ± 14%	Explore
ciliated cell	16 studies	53% ± 16%	Explore
endothelial cell of lymphatic vessel	15 studies	37% ± 12%	Explore
dendritic cell	15 studies	40% ± 24%	Explore
naive B cell	15 studies	23% ± 6%	Explore
mature NK T cell	15 studies	31% ± 5%	Explore
plasma cell	14 studies	41% ± 12%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	31% ± 9%	Explore
myeloid cell	14 studies	38% ± 17%	Explore
mast cell	13 studies	27% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	13 studies	26% ± 6%	Explore
connective tissue cell	13 studies	32% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	11 studies	32% ± 15%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	33% ± 9%	Explore
capillary endothelial cell	11 studies	23% ± 6%	Explore
vein endothelial cell	11 studies	26% ± 8%	Explore
plasmablast	10 studies	48% ± 22%	Explore
secretory cell	10 studies	35% ± 15%	Explore
CD16-negative, CD56-bright natural killer cell, human	10 studies	32% ± 7%	Explore
myofibroblast cell	10 studies	31% ± 8%	Explore
progenitor cell	10 studies	43% ± 17%	Explore
abnormal cell	10 studies	39% ± 20%	Explore
endothelial cell of artery	10 studies	24% ± 7%	Explore
goblet cell	10 studies	38% ± 18%	Explore
mucosal invariant T cell	10 studies	25% ± 5%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	31% ± 11%	Explore
effector memory CD8-positive, alpha-beta T cell	9 studies	29% ± 10%	Explore
endothelial cell of vascular tree	9 studies	25% ± 6%	Explore
type I pneumocyte	8 studies	34% ± 16%	Explore
enterocyte	8 studies	39% ± 18%	Explore
T follicular helper cell	8 studies	31% ± 9%	Explore
type II pneumocyte	7 studies	39% ± 20%	Explore
club cell	7 studies	44% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	40% ± 17%	Explore
leukocyte	7 studies	33% ± 15%	Explore
epithelial cell of proximal tubule	7 studies	53% ± 15%	Explore
mesothelial cell	7 studies	34% ± 16%	Explore
hematopoietic precursor cell	6 studies	39% ± 20%	Explore
respiratory goblet cell	6 studies	38% ± 16%	Explore
kidney loop of Henle epithelial cell	6 studies	48% ± 9%	Explore
neutrophil	6 studies	28% ± 11%	Explore
renal alpha-intercalated cell	6 studies	59% ± 10%	Explore
transit amplifying cell	6 studies	37% ± 21%	Explore
innate lymphoid cell	6 studies	27% ± 4%	Explore
neuron	6 studies	34% ± 17%	Explore
effector memory CD4-positive, alpha-beta T cell	6 studies	33% ± 15%	Explore
alveolar macrophage	5 studies	26% ± 6%	Explore
ionocyte	5 studies	40% ± 8%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	39% ± 9%	Explore
mononuclear phagocyte	5 studies	41% ± 18%	Explore
kidney distal convoluted tubule epithelial cell	5 studies	56% ± 8%	Explore
enteroendocrine cell	5 studies	43% ± 18%	Explore
retinal rod cell	5 studies	37% ± 19%	Explore
erythroblast	5 studies	42% ± 24%	Explore
pro-B cell	5 studies	35% ± 8%	Explore
brush cell	5 studies	29% ± 14%	Explore
erythrocyte	5 studies	42% ± 20%	Explore
intermediate monocyte	5 studies	52% ± 15%	Explore
deuterosomal cell	4 studies	43% ± 11%	Explore
pancreatic A cell	4 studies	49% ± 9%	Explore
type B pancreatic cell	4 studies	47% ± 18%	Explore
exhausted T cell	4 studies	49% ± 11%	Explore
glomerular endothelial cell	4 studies	29% ± 10%	Explore
intestinal crypt stem cell	4 studies	40% ± 14%	Explore
retinal ganglion cell	4 studies	63% ± 26%	Explore
retinal cone cell	4 studies	68% ± 24%	Explore
hematopoietic stem cell	4 studies	31% ± 8%	Explore
precursor B cell	4 studies	38% ± 12%	Explore
amacrine cell	4 studies	44% ± 18%	Explore
astrocyte	4 studies	33% ± 16%	Explore
microglial cell	4 studies	26% ± 10%	Explore
luminal hormone-sensing cell of mammary gland	4 studies	40% ± 7%	Explore
hepatocyte	4 studies	49% ± 31%	Explore
T-helper 17 cell	4 studies	32% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	4 studies	26% ± 7%	Explore
duct epithelial cell	3 studies	43% ± 9%	Explore
squamous epithelial cell	3 studies	44% ± 22%	Explore
podocyte	3 studies	43% ± 6%	Explore
neural crest cell	3 studies	36% ± 3%	Explore
IgG plasma cell	3 studies	25% ± 7%	Explore
retinal bipolar neuron	3 studies	53% ± 25%	Explore
ON-bipolar cell	3 studies	43% ± 22%	Explore
renal principal cell	3 studies	52% ± 1%	Explore
placental villous trophoblast	3 studies	45% ± 24%	Explore
lymphocyte	3 studies	45% ± 13%	Explore
neuroendocrine cell	3 studies	52% ± 21%	Explore
immature B cell	3 studies	30% ± 7%	Explore
retina horizontal cell	3 studies	45% ± 16%	Explore
serous secreting cell	3 studies	49% ± 19%	Explore
Mueller cell	3 studies	38% ± 10%	Explore
rod bipolar cell	3 studies	43% ± 20%	Explore
germinal center B cell	3 studies	41% ± 2%	Explore
inflammatory macrophage	3 studies	30% ± 8%	Explore
luminal cell of prostate epithelium	3 studies	36% ± 8%	Explore
pancreatic ductal cell	3 studies	47% ± 8%	Explore
oligodendrocyte precursor cell	3 studies	26% ± 5%	Explore
granulocyte	3 studies	26% ± 8%	Explore
glial cell	3 studies	34% ± 17%	Explore
group 3 innate lymphoid cell	3 studies	37% ± 16%	Explore
keratinocyte	3 studies	21% ± 2%	Explore
T-helper 1 cell	3 studies	35% ± 10%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	27% ± 8%	Explore
double negative thymocyte	3 studies	48% ± 20%	Explore
progenitor cell of mammary luminal epithelium	3 studies	24% ± 6%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	18 studies	32% ± 10%	Explore
lung	16 studies	37% ± 14%	Explore
intestine	12 studies	31% ± 17%	Explore
kidney	9 studies	39% ± 11%	Explore
eye	7 studies	36% ± 18%	Explore
liver	7 studies	35% ± 23%	Explore
brain	6 studies	24% ± 7%	Explore
bone marrow	5 studies	25% ± 6%	Explore
lymph node	5 studies	33% ± 11%	Explore
pancreas	4 studies	45% ± 16%	Explore
uterus	4 studies	41% ± 17%	Explore
breast	4 studies	28% ± 6%	Explore
placenta	3 studies	35% ± 19%	Explore
adrenal gland	3 studies	28% ± 3%	Explore
prostate	3 studies	20% ± 3%	Explore
thymus	3 studies	50% ± 19%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	2554.61	258 / 258	100%	89.38	230 / 230
brain	100%	1853.74	2642 / 2642	100%	57.31	705 / 705
esophagus	100%	1303.45	1445 / 1445	100%	32.27	183 / 183
kidney	100%	2612.39	89 / 89	100%	66.59	901 / 901
liver	100%	1575.71	226 / 226	100%	76.28	406 / 406
ovary	100%	1179.57	180 / 180	100%	81.87	430 / 430
thymus	100%	1512.66	653 / 653	100%	67.71	605 / 605
uterus	100%	1007.86	170 / 170	100%	67.17	459 / 459
pancreas	100%	847.23	327 / 328	100%	47.40	178 / 178
skin	100%	1179.13	1807 / 1809	100%	49.20	471 / 472
prostate	100%	1559.00	245 / 245	100%	80.74	500 / 502
intestine	100%	1524.63	966 / 966	99%	61.83	524 / 527
bladder	100%	1175.00	21 / 21	99%	60.17	500 / 504
stomach	100%	1467.26	359 / 359	99%	54.02	283 / 286
breast	100%	1497.64	459 / 459	99%	60.03	1106 / 1118
lung	99%	1215.21	575 / 578	99%	44.48	1145 / 1155
adipose	100%	1464.63	1204 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	100%	62.54	80 / 80
lymph node	0%	0	0 / 0	100%	110.11	29 / 29
muscle	100%	2400.66	803 / 803	0%	0	0 / 0
spleen	100%	1543.38	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	56.57	45 / 45
ureter	0%	0	0 / 0	100%	34.09	1 / 1
blood vessel	100%	1221.81	1331 / 1335	0%	0	0 / 0
heart	99%	2219.29	856 / 861	0%	0	0 / 0
peripheral blood	98%	1325.24	907 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0009060	Biological process	aerobic respiration
GO_0001835	Biological process	blastocyst hatching
GO_0006120	Biological process	mitochondrial electron transport, NADH to ubiquinone
GO_0042776	Biological process	proton motive force-driven mitochondrial ATP synthesis
GO_0055085	Biological process	transmembrane transport
GO_0032981	Biological process	mitochondrial respiratory chain complex I assembly
GO_0031966	Cellular component	mitochondrial membrane
GO_0045271	Cellular component	respiratory chain complex I
GO_0005743	Cellular component	mitochondrial inner membrane
GO_0008137	Molecular function	NADH dehydrogenase (ubiquinone) activity

Gene name	NDUFA2
Protein name	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit)
Synonyms
Description	FUNCTION: Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. .
Accessions	ENST00000252102.9 [O43678-1] ENST00000512088.1 [O43678-2] O43678

NDUFA2 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review